Ellis Investment Partners LLC Has $535,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Ellis Investment Partners LLC cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 11.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,675 shares of the financial services provider’s stock after selling 486 shares during the quarter. Ellis Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $535,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of IBB. Bbjs Financial Advisors LLC bought a new stake in iShares Biotechnology ETF in the second quarter valued at approximately $31,000. Eastern Bank bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $65,000. Chris Bulman Inc acquired a new stake in iShares Biotechnology ETF during the 2nd quarter worth $64,000. BNP Paribas bought a new position in iShares Biotechnology ETF during the first quarter worth about $69,000. Finally, Financial Perspectives Inc lifted its holdings in iShares Biotechnology ETF by 23.3% during the first quarter. Financial Perspectives Inc now owns 519 shares of the financial services provider’s stock worth $71,000 after acquiring an additional 98 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.1 %

Shares of iShares Biotechnology ETF stock traded down $0.08 during trading hours on Friday, hitting $141.51. The company’s stock had a trading volume of 745,368 shares, compared to its average volume of 996,185. The stock has a 50 day moving average of $145.56 and a 200 day moving average of $140.03. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.